1.Runping Su, Weijie, et al, Tao Zuo*. Dietary whey protein protects against Crohn’s disease by orchestrating cross-kingdom interaction between the gut phageome and bacteriome. Gut, 2025. (最后通讯，影响因子: 23)
2.Cao, Z., Fan, D., Sun, Y. et al, Tao Zuo*. The gut ileal mucosal virome is disturbed in patients with Crohn’s disease and exacerbates intestinal inflammation in mice. Nature Communications 15, 1638 (2024). (最后通讯，影响因子:14.7)
3.Ziyu Huang, Yunyun Liu, Anna Phillips, Fen Zhang, Tao Zuo*. Varied prevalence and asymptomatic carriage of Cryptococcus gattii in the gut of Chinese populations. Lancet Microbe. 2025 (独立通讯，影响因子: 20.9)
4.Nengneng Li, et al, Tao Zuo*. Fecal phageome transplantation alleviates intermittent intestinal inflammation in IBD and the timing of transplantation matters: a preclinical, proof-of-concept study in mice. Gut, 2024. (独立通讯，影响因子: 23)
5.Tao Zuo*. Dark Matter Beyond the bacteria in fecal microbiota transplantation. Nature Reviews Gastroenterology & Hepatology, 2022. (独立通讯，影响因子:45.9)
6.Fen Zhang, Dominik Aschenbrenner, Ji Youn Yoo, Tao Zuo*. The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly. 2022. Lancet Microbe. (独立通讯，影响因子:20.9)
7.Nengneng Li, et al, Tao Zuo*. Fecal phageome transplantation alleviates intermittent intestinal inflammation in IBD and the timing of transplantation matters: a preclinical, proof-of-concept study in mice. Gut, 2024. (独立通讯，影响因子:23)
8.Bai, X., Sun, Y., Li, Y. et al, Tao Zuo*. Landscape of the gut archaeome in association with geography, ethnicity, urbanization, and diet in the Chinese population. Microbiome 10, 147 (2022). (最后通讯，影响因子: 13.8)
9. Bai, X., et al, Tao Zuo*. Engineering the gut microbiome. Nature Reviews Bioengineering. 2023 (最后通讯)
10.Tao Zuo*. Gut bacteriophages ignite the mammalian immunity. Nature Reviews Microbiology, 21, 634, 2023. (独立通讯，影响因子: 69.2)
11.Ziyu Huang, Tao Zuo*. The gut microbiome: bridging medications and clinical outcomes post stem cell transplantation. Cell Host & Microbe (2023). (独立通讯，影响因子: 31.3)
12. Siu Lam, Xiaowu Bai, Andrey N Shkoporov, Heekuk Park, Xiaojian Wu, Ping Lan, Tao Zuo*. Roles of the gut virome and mycobiome in faecal microbiota transplantation. The Lancet Gastroenterology & Hepatology. (2022). (独立通讯，影响因子: 30.9)
13.Ziyu Huang, Yue Li, Heekuk Park, Martin Ho, Kanchan Bhardwaj, Naoki Sugimura, Hye Won Lee, Huicui Meng, Matthias P. Ebert, Kang Chao, Elke Burgermeister, Aadra P. Bhatt, Sudarshan A. Shetty, Kai Li1, Weiping Wen, Tao Zuo*. Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization. Gut Microbes. 2023 (最后通讯，影响因子: 12.2)
14.Tao Zuo#, Qin Liu#, Fen Zhang# et al. Depicting SARS-CoV-2 fecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut (2020). (第一作者，影响因子: 23)
15.Tao Zuo#, Yang Sun#, Yating Wan et al. Human Gut DNA Virome Variations across Geography, Ethnicity, and Urbanisation. Cell Host & Microbe (2020). (第一作者，影响因子:20.6)
16.Tao Zuo#, Fen Zhang# et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology (2020). https://doi.org/10.1053/j.gastro.2020.05.048. (第一作者，影响因子:25.7)
17.Tao Zuo#, Hui Zhan# et al. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalisation until Discharge. Gastroenterology(2020). (第一作者，影响因子:25.7)
18.Tao Zuo, et al. Gut mucosal virome alterations in ulcerative colitis. Gut (2019): gutjnl-2018. (第一作者，影响因子:23)
19.Tao Zuo, Siew C Ng. Authors response: giant oversights in the human gut virome. Gut, gutjnl-2019. (2019) (第一作者，影响因子:23)
20.Tao Zuo, Michael A. Kamm, Jean-Frédéric Colombel, Siew C Ng. Urbanization and the gut microbiota in health and inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology, 2018, 1. doi:10.1038/s41575-018-0003-z. (第一作者，影响因子:45.9)
21.Tao Zuo, Wong S H, Lam K, et al. Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome. Gut, 2018, 67(4):634-643. (第一作者，影响因子:23)
22.Tao Zuo, Sunny H Wong, et al. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. Nature Communications, 2018, doi: 10.1038/s41467-018-06103-6. (第一作者，影响因子:14.7)
23.Fen Zhang#, Tao Zuo#, Yun Kit Yeoh#, et al. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease. 2020. Nature Communications (并列第一第二位, 影响因子:14.7).
24.Yang Sun#, Tao Zuo#, et al. Population-level configurations of gut mycobiome across six ethnicities in urban and rural China. 2021. Gastroenterolgoy (并列第一第二位，影响因子: 25.7)
25.Yun Kit Yeoh#, Tao Zuo#, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in COVID-19 patients. Gut (2020). (并列第一第二位, 影响因子: 23)
26.Tao Zuo#, Liu Q#, Zhang F#, et al. Temporal Landscape of Human Gut virome in SARS-CoV-2 infection and severity. Microbiome. (2021) 9, 91. (第一作者，影响因子: 13.8)
27. Tao Zuo, Yun Kit Yeoh, Siew C Ng. Reply: The New Foe and Old Friends: Are We Ready for Microbiota-based Therapeutics in Treating COVID-19 Patients? Gastroenterolgoy (2021). (第一作者，影响因子: 25.7)
28.Zhirui Cao, Naoki Sugimura, Elke Burgermeister, Matthias P. Ebert, Tao Zuo*, and Ping Lan*. The gut virome: A new microbiome component in health and disease. eBioMedicine, 2022;81:104-113. (共同通讯，影响因子:9.7)
29.Tao Zuo*, Guangzhan Liang, et al. Baseline gut microbiome features prior to SARS-CoV-2 infection are associated with host symptoms in and post COVID-19. Journal of Medical Virology. 2023. (第一作者+共同通讯，影响因子:6.8)
30.Zuo T, Wu X, Wen W, et al. Gut Microbiome Alterations in COVID-19[J]. Genomics, Proteomics & Bioinformatics, 2021. (第一作者，影响因子：11.5)
